Self Defining Memories in Women Victims of Intimate Partner Violence.
NCT ID: NCT03906487
Last Updated: 2020-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2020-02-06
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence
NCT06718387
Attachment Style and Mentalization Impact Among Women Victims of Domestic Violence
NCT05331352
Addressing Intimate Partner Violence Among Women Veterans
NCT04106193
Violence Against Women and Consequences During Climacteric´s Phase
NCT01028118
Identification of Interpesonal Violence
NCT06322251
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Four elements will be study: specificity, meaning, content, affect.
The two groups will have two visits:
* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms;
* the last to characterize the SDM.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intimate partner violence
The women in this arm must have suffered at least two physical aggressions. They will be recruited in the study as part of their coming to the consultation of intentional injury of the medico-legal unit of the University Hospital Toulouse.
Assessment measures MINI, PCL5 and BDI-II and definition of 5 SDM
This group will have two visits:
* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing assessment measures called MINI, PCL-5, BDI-II ;
* the last to characterize the SDM by defining 5 personal memories
Control group
The women in this group are women who have never experienced domestic violence or have experienced a potentially traumatic event. These women will be recruited by a call for volunteers.
Assessment measures MINI and definition of 5 SDM
This group will have two visits:
* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing MINI questionary;
* the last to characterize the SDM by and defining 5 personal memories
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment measures MINI, PCL5 and BDI-II and definition of 5 SDM
This group will have two visits:
* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing assessment measures called MINI, PCL-5, BDI-II ;
* the last to characterize the SDM by defining 5 personal memories
Assessment measures MINI and definition of 5 SDM
This group will have two visits:
* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing MINI questionary;
* the last to characterize the SDM by and defining 5 personal memories
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* French mother tongue.
* Informed consent.
* Affiliated to social security
For women who are victims of IPV only:
* Having at least two physical aggressions
* To meet criterion A of the diagnosis of PTSD according to the Diagnostic and Statistical Manual of Mental Disorders DSM (DSM-5) (evaluated using the Mini International Neuropsychiatric Interview, MINI)
For women of the control group only:
\- None a victim of IPV
Exclusion Criteria
* Neurological pathology, brain damage.
* History of head trauma with loss of consciousness.
* Severe, progressive somatic pathology
* Psychotherapy in progress
* Taking psychotropic drugs or beta-blockers (because of their potential impact on memory capacity)
* Pregnant or lactating women
* Under a legal regime for the protection of adults
For women who are victims of IPV only:
* Antecedent or presence of PTSD other than that related to IPV
* History or presence of progressive mental disorders (Axis I DSM-5 - evaluated using Mini International Neuropsychiatric Interview, MINI)
For women of the control group only:
History or presence of progressive mental disorders including PTSD (Axis I DSM-5 - evaluated using Mini International Neuropsychiatric Interview, MINI)
18 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Damien PIERRE, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/19/0051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.